Category: Tulane Outbreak Daily

Tulane Outbreak Daily | June 5, 2020

Featured Headlines The biggest mystery: what it will take to trace the coronavirus source – Nature SARS-CoV-2 came from an animal but finding which one will be tricky, as will laying to rest speculation of a lab escape. Bloomberg Podcast:…

Tulane Outbreak Daily | June 4, 2020

Upcoming Virtual Events Today! COVID-19 Open Online Briefings with Dr David Nabarro Featured Headlines Dr. Anthony Fauci says there’s a chance coronavirus vaccine may not provide immunity for very long – CNBC If Covid-19 acts like other coronaviruses, “it likely…

Tulane Outbreak Daily | June 3, 2020

  Featured Headlines Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July – Forbes Dr. Anthony Fauci said the Phase 3 trial of Moderna’s experimental COVID-19 vaccine will begin in July and include study of…

Tulane Outbreak Daily | June 2, 2020

Upcoming Virtual Events COVID-19 Response: Promising Practices in Health Equity June 2, 2020 3-4pm ET Featured Headlines Several articles out on impact of COVID-19 and protests in the United States, here are a few: Will Protests Set Off a Second…

Tulane Outbreak Daily | May 29, 2020

Some of the links below may require registration or subscription. Upcoming Virtual Events COVID-19 Response: Promising Practices in Health Equity June 2, 2020 3-4pm ET Featured Headlines Fauci’s testimony warning against reopening too soon, in less than 3 minutes –…

Tulane Outbreak Daily | May 28, 2020

Featured Headlines ‘It’s Too Late’: In Sprawling Indonesia, Coronavirus Surges – NYT A random sampling of thousands found that one in 10 had antibodies for the coronavirus, an alarming glimpse at what could be runaway transmission. Brazil Counts Almost Twice…

Tulane Outbreak Daily | May 27, 2020

Featured Headlines Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans – Science Merck, one of the largest pharmaceutical companies in the world, has been conspicuously absent from the race to develop COVID-19 vaccines and…

Tulane Outbreak Daily | May 26, 2020

Featured Headlines ​Remdesivir Data from NIAID Trial Published – MedPageToday Hospitalized patients with COVID-19 who received remdesivir had a median recovery time of 11 days versus 15 days with placebo (rate ratio for recovery 1.32, 95% CI 1.12-1.55, P<0.001), reported…

Tulane Outbreak Daily | May 22, 2020

Thank you! Great response to the reader survey, and we are implementing some excellent suggestions we received in the comments. Featured Headlines ​China’s New Outbreak Shows Signs the Virus Could Be Changing​ – Bloomberg Chinese doctors are seeing the coronavirus…

Tulane Outbreak Daily | May 21, 2020

Reader Survey Results If you filled out the Quick and Painless Survey thanks! If you have not, please do. What we learned from your responses The Tulane Outbreak Daily has 3,088 subscribers from all over the world. Countries include; United States,…